Erythropoietin (Epo) has been thought to act exclusively on erythroid progenitor cells. The
identification of Epo receptor (EpoR) in non-haematopoietic cells and tissues including …

Discovered as the primary regulator of erythropoiesis, erythropoietin (EPO) is involved in a
broad variety of processes that play a major role in cardiovascular diseases. In particular …

Erythropoietin (Epo) was once thought to act exclusively in the formation of red blood cells.
As recently reviewed by Smith et al.[Cardiovasc. Res. 59 (2003) 538–548], Epo can also act …

Erythropoietin (EPO), a glycoprotein essential for red blood cell production acts on several
non-erythropoietic tissues. The EPO receptor (EPOR) is expressed in a variety of cell types …

Erythropoietin (EPO) is a hypoxia-induced hormone produced in the kidneys that stimulates
hematopoiesis in the bone marrow. However, recent studies have also shown important …

Erythropoietin (EPO) is a principal regulator that promotes proliferation and terminal
differentiation of erythroid progenitor cells. EPO receptors are expressed not only in …

Erythropoietin (EPO) is a 30,400 daltons glycoprotein, consisting of 165 amino acids
produced mainly in the kidney and in the liver and regulating erythrocyitosis. It primarily acts …

Erythropoietin (EPO) is not solely a hormone charged with regulating the proliferation and
differentiation of erythroid cells. Indeed, EPO is synthesized locally by many cells, especially …

Erythropoietin (EPO) is the main hormone that regulates erythropoiesis. Beyond its well-
known hematopoietic action, EPO has diverse cellular effects in non-hematopoietic tissues …

Erythropoietin (EPO) is a 30.4-kDa glycoprotein essential for red blood cell production. In
adults, EPO is produced primarily in the kidney via an oxygen-sensing mechanism and …